3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
NIH
1
NETWORK
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
90
Prostatic Neoplasms
55
Lymphoma
34
Leukemia
32
Carcinoma, Non-Small-Cell Lung
31
Multiple Myeloma
30
Head and Neck Neoplasms
30
Colorectal Neoplasms
29
Squamous Cell Carcinoma of Head and Neck
28
Lung Neoplasms
27
Precursor Cell Lymphoblastic Leukemia-Lymphoma
25
Colonic Neoplasms
24
Leukemia, Myeloid, Acute
22
Rectal Neoplasms
21
Neoplasm Metastasis
20
Sarcoma
19
Ovarian Neoplasms
19
Central Nervous System Neoplasms
18
Uterine Cervical Neoplasms
17
Hodgkin Disease
17
Burkitt Lymphoma
15
Brain Neoplasms
15
Carcinoma, Ovarian Epithelial
14
Pain
12
Lymphoma, Follicular
12
Urinary Bladder Neoplasms
11
Lymphoma, Large B-Cell, Diffuse
11
Fallopian Tube Neoplasms
11
Endometrial Neoplasms
11
Astrocytoma
11
Interventions
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
NETWORK
×
Amyloidosis
×
Clear all
NCT01277016
2017-03-10
EMN-03
European Myeloma Network B.V.
Phase 3
Completed
110 enrolled